共 50 条
- [1] Effects of adding fenofibrate in high risk patients with combined hyperlipidemia not controlled by pravastatinATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 554 - 554Farnier, M.Ducobu, J.Bryniarski, L.
- [2] EFFECTS OF A FIXED COMBINATION OF FENOFIBRATE AND PRAVASTATIN ON APOLIPOPROTEINS IN HIGH RISK PATIENTS WITH MIXED HYPERLIPIDEMIAATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 193 - 193Ducobu, J.Farnier, M.Fruchart, J. C.
- [3] Long-term safety and efficacy of fenofibrate/pravastatin combination therapy in high risk patients with mixed hyperlipidemia not controlled by pravastatin monotherapyCURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (11) : 2165 - 2173Farnier, MichelDucobu, JeanBryniarski, Leszek
- [5] Comparison of micronized fenofibrate and pravastatin in patients with primary hyperlipidemiaJOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2003, 41 (01) : 60 - 67Ducobu, JVanHaelst, LSalomon, H
- [6] Efficacy and Safety of Adding Fenofibrate 160 mg in High-Risk Patients With Mixed Hyperlipidemia Not Controlled by Pravastatin 40 mg monotherapyAMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (06): : 787 - 792Farnier, MichelDucobu, JeanBryniarski, Leszek
- [7] SAFETY AND EFFICACY OF LONG-TERM ADMINISTRATION OF A FENOFIBRATE/PRAVASTATIN FIXED COMBINATION IN HIGH RISK PATIENTS WITH MIXED HYPERLIPIDEMIAATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 192 - 193Farnier, M.Ducobu, J.Bryniarski, L.
- [8] Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of patients with combined hyperlipidemiaJOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 394A - 394AKoh, KKHan, SHQuon, MJChung, WJShin, MSAhn, THChoi, ISShin, EK
- [10] Effects of micronized fenofibrate on apo A defined HDL subfractions in patients with combined hyperlipidemiaATHEROSCLEROSIS, 1998, 138 : S8 - S8Branchi, ARovellini, AFiorenza, AMSommariva, D